Polymer-based drug delivery systems for anticancer drugs: A systematic review

Jahanshahi, 2008, Gelatin nanoparticle fabrication and optimization of the particle size, Phys. Status Solidi (a), 205, 2898, 10.1002/pssa.200824329 Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Deliv. Rev, 55, 329, 10.1016/S0169-409X(02)00228-4 Park, 2010, Targeted delivery of low molecular drugs using chitosan and its derivatives, Adv. Drug Deliv. Rev, 62, 28, 10.1016/j.addr.2009.10.003 Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev.-Columbus, 99, 3181, 10.1021/cr940351u Kulkarni Vishakha, 2012, Natural polymers-A comprehensive review, Int. J. Res. Pharm. Biomed. Sci, 3, 1597 Yuan, 1995, Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size, Cancer Res, 55, 3752 Patra, 2018, Nano based drug delivery systems: recent developments and future prospects, J. Nanobiotechnology, 16, 1, 10.1186/s12951-018-0392-8 Zhou, 2016, Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-lapachone delivery, J. Mater. Chem. B, 4, 7429, 10.1039/C6TB02049F Nair, 2007, Biodegradable polymers as biomaterials, Prog. Polym. Sci, 32, 762, 10.1016/j.progpolymsci.2007.05.017 Kamaly, 2016, Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release, Chem. Rev., 116, 2602, 10.1021/acs.chemrev.5b00346 Xu, 2015, Cancer nanomedicine: from targeted delivery to combination therapy, Trends Mol. Med, 21, 223, 10.1016/j.molmed.2015.01.001 Makadia, 2011, Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier, Polymers (Basel), 3, 1377, 10.3390/polym3031377 Kumari, 2010, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B: Biointerfaces, 75, 1, 10.1016/j.colsurfb.2009.09.001 Gandhi, 2012, Polymers in pharmaceutical drug delivery system: a review, Int. J. Pharm. Sci. Rev. Res, 14, 57 Moher, 2011, PRISMA statement, Epidemiology, 22, 128, 10.1097/EDE.0b013e3181fe7825 Schulz, 2010, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, Trials, 11, 1, 10.1186/1745-6215-11-32 Whiting, 2003, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Med. Res. Methodol, 3, 25, 10.1186/1471-2288-3-25 Tao, 2013, Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy, Acta Biomater, 9, 8910, 10.1016/j.actbio.2013.06.034 Dehghan Kelishady, 2015, Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation, Pharm. Dev. Technol, 20, 1009, 10.3109/10837450.2014.965323 Bressler, 2018, Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells, J. Biomed. Mater. Res. A, 106, 1753, 10.1002/jbm.a.36360 Nicolas, 2018, Polymeric nanocapsules as drug carriers for sustained anticancer activity of calcitriol in breast cancer cells, Int. J. Pharm, 550, 170, 10.1016/j.ijpharm.2018.08.022 Mehata, 2019, Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy, Colloids Surf. B: Biointerfaces, 173, 366, 10.1016/j.colsurfb.2018.10.007 Anzar, 2018, Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer, J. Mol. Liq, 249, 609, 10.1016/j.molliq.2017.11.081 Huang, 2010, Glycyrrhetinic acid-modified poly (ethylene glycol)-b-poly (γ-benzyl L-glutamate) micelles for liver targeting therapy, Acta Biomater, 6, 3927, 10.1016/j.actbio.2010.04.021 Massadeh, 2020, Optimized polyethylene glycolylated polymer-lipid hybrid nanoparticles as a potential breast cancer treatment, Pharmaceutics, 12, 666, 10.3390/pharmaceutics12070666 Alemrayat, 2019, Preparation and characterization of letrozole-loaded poly (d, L-lactide) nanoparticles for drug delivery in breast cancer therapy, Pharm. Dev. Technol, 24, 235, 10.1080/10837450.2018.1455698 Zeighamian, 2016, PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells, Artif. Cells Nanomed. Biotechnol, 44, 735, 10.3109/21691401.2014.982803 Tang, 2013, Paclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatment, Nanoscale Res. Lett, 8, 1, 10.1186/1556-276X-8-420 Zhang, 2012, Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation, J. Control. Release, 159, 429, 10.1016/j.jconrel.2012.01.031 Zhao, 2014, CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy, Nanomed.: Nanotechnol., Biol. Med., 10, 1221, 10.1016/j.nano.2014.02.015 Tahir, 2019, Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy, Int. J. Nanomed, 14, 4961, 10.2147/IJN.S209325 Bhardwaj, 2009, PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat, Pharm. Res., 26, 2495, 10.1007/s11095-009-9965-4 Jadon, 2019, Docetaxel-loaded lipid-polymer hybrid nanoparticles for breast cancer therapeutics, J. Drug Deliv. Sci. Technol, 51, 475, 10.1016/j.jddst.2019.03.039 Soe, 2019, Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast cancer cells, Pharmaceutics, 11, 63, 10.3390/pharmaceutics11020063 He, 2011, PEGylated Poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors, Biomaterials, 32, 478, 10.1016/j.biomaterials.2010.09.002 Kim, 2001, Specific binding of glucose-derivatized polymers to the asialoglycoprotein receptor of mouse primary hepatocytes, J. Biol. Chem, 276, 35312, 10.1074/jbc.M009749200 Zubris, 2013, In vitro activity of paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells, Biomacromolecules, 14, 2074, 10.1021/bm400434h He, 2015, Poly (ethylene glycol)-block-poly (ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery, Int. J. Nanomed, 10, 1791 Li, 2014, A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer, ACS Nano, 8, 9925, 10.1021/nn501069c Patel, 2016, Ligand anchored poly (propyleneimine) dendrimers for brain targeting: comparative in vitro and in vivo assessment, J. Colloid Interface Sci, 482, 142, 10.1016/j.jcis.2016.07.047 Panda, 2019, Engineered polymeric iron oxide nanoparticles as potential drug carrier for targeted delivery of docetaxel to breast cancer cells, J. Magn. Magn. Mater, 485, 165, 10.1016/j.jmmm.2019.04.058 Zhou, 2017, Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle, Int. J. Pharm, 530, 300, 10.1016/j.ijpharm.2017.07.085 I El-Gogary, 2019, Polymeric nanocapsular baicalin: chemometric optimization, physicochemical characterization and mechanistic anticancer approaches on breast cancer cell lines, Sci. Rep, 9, 11064, 10.1038/s41598-019-47586-7 Chen, 2011, Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer, Drug Dev. Ind. Pharm, 37, 1339, 10.3109/03639045.2011.575162 He, 2017, Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer, J. Control. Release, 246, 98, 10.1016/j.jconrel.2016.12.019 Maji, 2014, Mondal S. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy, Int. J. Nanomed, 9, 3107 Pa, 2010, Lactose mediated liver-targeting effect observed by ex vivo imaging technology, Biomaterials, 31, 2646, 10.1016/j.biomaterials.2009.12.019 Talaei, 2011, Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells, Int. J. Nanomed, 6, 1963 Shenoy, 2005, Poly (ethylene oxide)-modified poly (ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer, Int. J. Pharm, 293, 261, 10.1016/j.ijpharm.2004.12.010 Xu, 2017, Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma, Carbohydr. Polym, 157, 419, 10.1016/j.carbpol.2016.09.085 Chowdhury, 2018, Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer, Acta Pharm. Sin. B, 8, 602, 10.1016/j.apsb.2017.10.004 Verderio, 2013, Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells, Biomacromolecules, 14, 672, 10.1021/bm3017324 Zhou, 2014, Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells, J. Drug Target, 22, 57, 10.3109/1061186X.2013.839683 Yang, 2007, Antibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancer, J. Mater. Chem, 17, 2695, 10.1039/b702538f Fazil, 2012, Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting, Eur. J. Pharm. Sci, 47, 6, 10.1016/j.ejps.2012.04.013 Soni, 2015, Dual drug-loaded paclitaxel-thymoquinone nanoparticles for effective breast cancer therapy, J. Nanoparticle Res, 17, 18, 10.1007/s11051-014-2821-4 Agrawal, 2015, Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting, Colloids Surf. B: Biointerfaces, 126, 414, 10.1016/j.colsurfb.2014.12.045 Elbaz, 2016, Core-shell silver/polymeric nanoparticles-based combinatorial therapy against breast cancer in-vitro, Sci. Rep, 6, 30729, 10.1038/srep30729 Vivek, 2014, Multifunctional HER2-antibody conjugated polymeric nanocarrier-based drug delivery system for multi-drug-resistant breast cancer therapy, ACS Appl. Mater. Interfaces, 6, 6469, 10.1021/am406012g Yuan, 2018, pH-sensitive polymeric nanoparticles of mPEG-PLGA-PGlu with hybrid core for simultaneous encapsulation of curcumin and doxorubicin to kill the heterogeneous tumour cells in breast cancer, Artif. Cells Nanomed. Biotechnol, 46, 302, 10.1080/21691401.2017.1423495 Zhang, 2017, ROS-switchable polymeric nanoplatform with stimuli-responsive release for active targeted drug delivery to breast cancer, ACS Appl. Mater. Interfaces, 9, 12227, 10.1021/acsami.6b16815 Brigger, 2002, Poly (ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting, J. Pharmacol. Exp. Ther, 303, 928, 10.1124/jpet.102.039669 Mei, 2009, A novel docetaxel-loaded poly (ε-Caprolactone)/Pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment, Nanoscale Res. Lett, 4, 1530, 10.1007/s11671-009-9431-6 Liang, 2006, Paclitaxel-loaded poly (γ-glutamic acid)-poly (lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer, Biomaterials, 27, 2051, 10.1016/j.biomaterials.2005.10.027 Wu, 2015, Novel simvastatin-loaded nanoparticles based on cholic acid-core star-shaped PLGA for breast cancer treatment, J. Biomed. Nanotechnol, 11, 1247, 10.1166/jbn.2015.2068 Wong, 2006, Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer, J. Control. Release, 116, 275, 10.1016/j.jconrel.2006.09.007 Sun, 2008, Multifunctional poly (d,l-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by trastuzumab for targeted chemotherapy of breast cancer, Biomaterials, 29, 475, 10.1016/j.biomaterials.2007.09.038 Das, 2005, Double-coated poly (Butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration, J. Pharm. Sci, 94, 1343, 10.1002/jps.20357 Katiyar, 2016, Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment, Drug Deliv, 23, 2608, 10.3109/10717544.2015.1039667 Varukattu, 2020, Nanostructured pH-responsive biocompatible chitosan coated copper oxide nanoparticles: a polymeric smart intracellular delivery system for doxorubicin in breast cancer cells, Arab. J. Chem, 13, 2276, 10.1016/j.arabjc.2018.04.012 Hong, 2008, Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs, Biomed. Microdevices, 10, 693, 10.1007/s10544-008-9180-9 Muntimadugu, 2016, CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel, Colloids Surf. B: Biointerfaces, 143, 532, 10.1016/j.colsurfb.2016.03.075 Acharya, 2009, Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy, Biomaterials, 30, 5737, 10.1016/j.biomaterials.2009.07.008 Shen, 2011, Poly (ethylene glycol)-block-poly (D,L-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery, J. Drug Target, 19, 197, 10.3109/1061186X.2010.483517 Jain, 2011, Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model, Mol. Pharm., 8, 1140, 10.1021/mp200011f Hashida, 1999, Design of polymeric prodrugs of prostaglandin E1 having galactose residue for hepatocyte targeting, J. Control. Release, 62, 253, 10.1016/S0168-3659(99)00045-0 Tan, 2017, A novel MPEG-PDLLA-PLL copolymer for docetaxel delivery in breast cancer therapy, Theranostics, 7, 2652, 10.7150/thno.19680 Wan, 2019, Co-delivery of paclitaxel and cisplatin in poly (2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments, Biomaterials, 192, 1, 10.1016/j.biomaterials.2018.10.032 Vakilinezhad, 2019, Methotrexate and curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: in vitro and in vivo evaluation, Colloids Surf B: Biointerfaces, 184, 10.1016/j.colsurfb.2019.110515 Zeng, 2017, Lipid-polymer hybrid nanoparticles for synergistic drug delivery to overcome cancer drug resistance, New J. Chem, 41, 1518, 10.1039/C6NJ02819E Tavassolian, 2014, Targeted poly (l-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells, Int. J. Pharm, 467, 123, 10.1016/j.ijpharm.2014.03.033 Anari, 2016, Chrysin-loaded PLGA-PEG nanoparticles designed for enhanced effect on the breast cancer cell line, Artif. Cells Nanomed. Biotechnol, 44, 1410, 10.3109/21691401.2015.1029633 Markeb, 2016, Synthesis, structural characterization, and preclinical efficacy of a novel paclitaxel-loaded alginate nanoparticle for breast cancer treatment, Int. J. Breast Cancer, 10.1155/2016/7549372 Chan, 2009, PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery, Biomaterials, 30, 1627, 10.1016/j.biomaterials.2008.12.013 Thadakapally, 2016, Preparation and characterization of PEG-albumin-curcumin nanoparticles intended to treat breast cancer, Indian J. Pharm. Sci, 78, 65, 10.4103/0250-474X.180250 Yewale, 2018, Docetaxel loaded immunonanoparticles delivery in EGFR overexpressed breast carcinoma cells, J. Drug Deliv. Sci. Technol, 45, 334, 10.1016/j.jddst.2018.03.027 Saxena, 2012, Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer, Colloids Surf. B: Biointerfaces, 94, 274, 10.1016/j.colsurfb.2012.02.001 Jithan, 2011, Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer, Int. J. Pharm. Investig, 1, 119, 10.4103/2230-973X.82432 J Mitchell, 2021, Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov, 20, 101, 10.1038/s41573-020-0090-8 Angelova, 1999, Rationalizing the design of polymeric biomaterials, Trends Biotechnol, 17, 10.1016/S0167-7799(99)01356-6 Hamidi, 2008, Hydrogel nanoparticles in drug delivery, Adv. Drug Deliv. Rev, 60, 1638, 10.1016/j.addr.2008.08.002 Abdel-Naby, 2014, Chemical modification of cellulose acetate by N- (phenyl amino) maleimides: characterization and properties, Int. J. Biol. Macromol, 68, 21, 10.1016/j.ijbiomac.2014.04.007 Cumpstey, 2013, Chemical modification of polysaccharides, ISRN Org. Chem, 10.1155/2013/417672 DeSantis, 2014, Breast cancer statistics, 2013, CA Cancer J. Clin, 64, 52, 10.3322/caac.21203 Hao, 2021, 5-Boronopicolinic acid-functionalized polymeric nanoparticles for targeting drug delivery and enhanced tumor therapy, Mater. Sci. Eng. C Mater. Biol. Appl, 119, 10.1016/j.msec.2020.111553 Balasundaram, 2015, Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer, Int. J. Nanomed, 10, 387, 10.2147/IJN.S73558 Stelzer, 2013, Epidemiology and prognosis of brain metastases, Surg. Neurol. Int, 4, S192, 10.4103/2152-7806.111296 Arshad, 2010, Blood-brain barrier integrity and breast cancer metastasis to the brain, Patholog. Res. Int Huang, 2008, The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain, Biomaterials, 29, 238, 10.1016/j.biomaterials.2007.09.024 Shin, 1995, Transferrin-antibody fusion proteins are effective in brain targeting, Proc. Natl. Acad. Sci, 92, 2820, 10.1073/pnas.92.7.2820 Ren, 2012, The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2, Biomaterials, 33, 3324, 10.1016/j.biomaterials.2012.01.025 Bosch, 2004, Primary liver cancer: worldwide incidence and trends, Gastroenterology, 127, S5, 10.1053/j.gastro.2004.09.011 Perz, 2006, The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide, J. Hepatol., 45, 529, 10.1016/j.jhep.2006.05.013 Chong, 2005, Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery, J. Control. Release, 102, 85, 10.1016/j.jconrel.2004.09.014